Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Use of narcotic antagonists to modify stereotypic self-licking, self-chewing, and scratching behavior in dogs.

Dodman NH, Shuster L, White SD, Court MH, Parker D, Dixon R.

J Am Vet Med Assoc. 1988 Oct 1;193(7):815-9.

PMID:
3192459
2.

Naltrexone-induced pruritus in a dog with tail-chasing behavior.

Schwartz S.

J Am Vet Med Assoc. 1993 Jan 15;202(2):278-80.

PMID:
8428834
3.

Effects of naltrexone on spontaneous itch-associated responses in NC mice with chronic dermatitis.

Maekawa T, Yamaguchi-Miyamoto T, Nojima H, Kuraishi Y.

Jpn J Pharmacol. 2002 Oct;90(2):193-6.

4.

A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long-acting opiod antagonist nalmefene in subjects with atopic dermatitis.

Herzog JL, Solomon JA, Draelos Z, Fleischer A Jr, Stough D, Wolf DI, Abramovits W, Werschler W, Green E, Duffy M, Rothaul A, Tansley R.

J Drugs Dermatol. 2011 Aug;10(8):853-60.

PMID:
21818506
5.

Naltrexone for treatment of acral lick dermatitis in dogs.

White SD.

J Am Vet Med Assoc. 1990 Apr 1;196(7):1073-6.

PMID:
2329076
6.
7.

Use of a narcotic antagonist (nalmefene) to suppress self-mutilative behavior in a stallion.

Dodman NH, Shuster L, Court MH, Patel J.

J Am Vet Med Assoc. 1988 Jun 1;192(11):1585-6.

PMID:
3410777
8.

Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study.

Bergasa NV, Alling DW, Talbot TL, Wells MC, Jones EA.

J Am Acad Dermatol. 1999 Sep;41(3 Pt 1):431-4.

PMID:
10459118
9.

The use of dextromethorphan to treat repetitive self-directed scratching, biting, or chewing in dogs with allergic dermatitis.

Dodman NH, Shuster L, Nesbitt G, Weissman A, Lo WY, Chang WW, Cottam N.

J Vet Pharmacol Ther. 2004 Apr;27(2):99-104.

PMID:
15096107
10.

Inhibition of passive cutaneous anaphylaxis-associated scratching behavior by mu-opioid receptor antagonists in ICR mice.

Inagaki N, Nakamura N, Nagao M, Kawasaki H, Nagai H.

Int Arch Allergy Immunol. 2000 Dec;123(4):365-8.

PMID:
11146395
11.

Open-label trial of oral nalmefene therapy for the pruritus of cholestasis.

Bergasa NV, Schmitt JM, Talbot TL, Alling DW, Swain MG, Turner ML, Jenkins JB, Jones EA.

Hepatology. 1998 Mar;27(3):679-84.

PMID:
9500694
12.

Duration of opioid antagonism by nalmefene and naloxone in the dog. A nonparametric pharmacodynamic comparison based on generalized cross-validated spline estimation.

Wilhelm JA, Veng-Pedersen P, Zakszewski TB, Osifchin E, Waters SJ.

Int J Clin Pharmacol Ther. 1995 Oct;33(10):540-5.

PMID:
8574503
13.
14.

Successful treatment of refractory aquagenic pruritus with naltrexone.

Ingber S, Cohen PD.

J Cutan Med Surg. 2005 Oct;9(5):215-6.

PMID:
16502200
15.

The opioid receptor antagonist nalmefene reduces responding maintained by ethanol presentation: preclinical studies in ethanol-preferring and outbred Wistar rats.

June HL, Grey C, Warren-Reese C, Durr LF, Ricks-Cord A, Johnson A, McCane S, Williams LS, Mason D, Cummings R, Lawrence A.

Alcohol Clin Exp Res. 1998 Dec;22(9):2174-85.

PMID:
9884166
16.

Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study.

Malekzad F, Arbabi M, Mohtasham N, Toosi P, Jaberian M, Mohajer M, Mohammadi MR, Roodsari MR, Nasiri S.

J Eur Acad Dermatol Venereol. 2009 Aug;23(8):948-50. doi: 10.1111/j.1468-3083.2009.03129.x. Epub 2009 May 6.

PMID:
19453814
17.

Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study.

Pauli-Magnus C, Mikus G, Alscher DM, Kirschner T, Nagel W, Gugeler N, Risler T, Berger ED, Kuhlmann U, Mettang T.

J Am Soc Nephrol. 2000 Mar;11(3):514-9.

18.

Efficacy and safety of nalmefene in patients with severe pruritus caused by chronic urticaria and atopic dermatitis.

Monroe EW.

J Am Acad Dermatol. 1989 Jul;21(1):135-6. No abstract available.

PMID:
2745760
19.

Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system.

Umeuchi H, Togashi Y, Honda T, Nakao K, Okano K, Tanaka T, Nagase H.

Eur J Pharmacol. 2003 Sep 5;477(1):29-35.

PMID:
14512095
20.

Treatment of pruritus with topically applied opiate receptor antagonist.

Bigliardi PL, Stammer H, Jost G, Rufli T, B├╝chner S, Bigliardi-Qi M.

J Am Acad Dermatol. 2007 Jun;56(6):979-88. Epub 2007 Feb 22.

PMID:
17320241
Items per page

Supplemental Content

Write to the Help Desk